Prospective study of endogenous tissue plasminogen activator and risk of stroke

[1]  W. Chandler,et al.  Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). , 1989, Circulation.

[2]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[3]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[4]  A. Maseri,et al.  Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. , 1988, The American journal of cardiology.

[5]  H. Hamaguchi,et al.  High Serum Lipoprotein (a) Levels Are an Independent Risk Factor for Cerebral Infarction , 1993, Stroke.

[6]  B. Winblad,et al.  Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. , 1986, Clinical chemistry.

[7]  W. Feinberg,et al.  Hemostatic markers in acute stroke. , 1989, Stroke.

[8]  P. Ridker,et al.  Endogenous tissue-type plasminogen activator and risk of myocardial infarction , 1993, The Lancet.

[9]  M. Marmot,et al.  Primary prevention of stroke , 1992, The Lancet.

[10]  P. Ridker.  An epidemiologic assessment of thrombotic risk factors for cardiovascular disease , 1992 .

[11]  T. Meade,et al.  Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study , 1993, The Lancet.

[12]  M. Blombäck,et al.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.

[13]  K. Asplund,et al.  Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen: A population study , 1993 .

[14]  N. Kokolis,et al.  Fatty streaks and fibrous plaques in human aorta show increased plasminogen activator activity. , 1988, Haemostasis.

[15]  W. Wijns,et al.  Regional wall motion abnormalities in stunned and hibernating myocardium. , 1993, European heart journal.

[16]  M. Blombäck,et al.  PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION , 1987, The Lancet.

[17]  C. Lucore.  Regulation of fibrinolysis by vascular endothelium , 1991 .

[18]  H. R. Martinez,et al.  Ischemic Stroke Due to Deficiency of Coagulation Inhibitors: Report of 10 Young Adults , 1993, Stroke.

[19]  R. D'Agostino,et al.  Fibrinogen and risk of cardiovascular disease. The Framingham Study. , 1987, JAMA.

[20]  R. Hart,et al.  Hematologic disorders and ischemic stroke. A selective review. , 1990, Stroke.

[21]  K. Pfeiffer,et al.  Lipoprotein(a) as a strong indicator for cerebrovascular disease. , 1986, Stroke.

[22]  M. Underwood,et al.  Increased fibrinolytic activity in the intima of atheromatous coronary arteries: protection at a price. , 1993, Cardiovascular research.

[23]  David C. Atkins,et al.  Cholesterol Reduction and the Risk for Stroke in Men , 1993, Annals of Internal Medicine.